SG11202107183VA - Formulations containing active oxygen compounds and devices for application thereof - Google Patents

Formulations containing active oxygen compounds and devices for application thereof

Info

Publication number
SG11202107183VA
SG11202107183VA SG11202107183VA SG11202107183VA SG11202107183VA SG 11202107183V A SG11202107183V A SG 11202107183VA SG 11202107183V A SG11202107183V A SG 11202107183VA SG 11202107183V A SG11202107183V A SG 11202107183VA SG 11202107183V A SG11202107183V A SG 11202107183VA
Authority
SG
Singapore
Prior art keywords
devices
application
active oxygen
formulations containing
containing active
Prior art date
Application number
SG11202107183VA
Inventor
Majcen Dominika Tompa
Original Assignee
Majcen Dominika Tompa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Majcen Dominika Tompa filed Critical Majcen Dominika Tompa
Publication of SG11202107183VA publication Critical patent/SG11202107183VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22Peroxides; Oxygen; Ozone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38Percompounds, e.g. peracids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87Application Devices; Containers; Packaging
SG11202107183VA 2019-01-14 2020-01-14 Formulations containing active oxygen compounds and devices for application thereof SG11202107183VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI201900011A SI25540A (en) 2019-01-14 2019-01-14 Formulations with active oxygen compounds and accessories for their application
PCT/IB2020/050257 WO2020148642A1 (en) 2019-01-14 2020-01-14 Formulations containing active oxygen compounds and devices for application thereof

Publications (1)

Publication Number Publication Date
SG11202107183VA true SG11202107183VA (en) 2021-07-29

Family

ID=66635608

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107183VA SG11202107183VA (en) 2019-01-14 2020-01-14 Formulations containing active oxygen compounds and devices for application thereof

Country Status (20)

Country Link
US (1) US20220062124A1 (en)
EP (1) EP3790529B8 (en)
JP (1) JP2022522399A (en)
KR (1) KR102651050B1 (en)
CN (1) CN113365597A (en)
AU (1) AU2020210126B2 (en)
BR (1) BR112021013705A2 (en)
CA (1) CA3109813A1 (en)
DK (1) DK3790529T5 (en)
ES (1) ES2934987T3 (en)
FI (1) FI3790529T3 (en)
HR (1) HRP20221515T1 (en)
HU (1) HUE061288T2 (en)
LT (1) LT3790529T (en)
MX (1) MX2021008491A (en)
MY (1) MY194346A (en)
SG (1) SG11202107183VA (en)
SI (2) SI25540A (en)
WO (1) WO2020148642A1 (en)
ZA (1) ZA202105832B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000016984A1 (en) * 2020-07-13 2022-01-13 Bmg Pharma S P A SANITIZING AND ANTIINFECTIVE COMPOSITIONS FOR ORAL MUCOSA
DE102021108264A1 (en) * 2021-03-31 2022-10-06 G. Pohl-Boskamp Gmbh & Co. Kg A composition for topical application to a subject

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2111912A (en) * 1935-10-19 1938-03-22 Govett Thomas Colloidal gold-containing cream
LU85789A1 (en) 1985-02-26 1986-09-02 Oreal USE IN THE THERAPEUTIC AND COSMETIC FIELDS OF AN ANHYDROUS SOLUTION OF HYDROGEN PEROXIDE
DE4123292C2 (en) * 1991-07-13 1996-01-25 Hungerbach Chemotechnik Gmbh Oral hygiene and use of a silver colloid stabilized hydrogen peroxide solution in oral hygiene products
KR970007425A (en) * 1995-07-12 1997-02-21 김광호 Liquid crystal display
US5928628A (en) * 1997-10-23 1999-07-27 Pellico; Michael A. Two-component dental bleaching system and method
US6673374B2 (en) * 1998-07-31 2004-01-06 Howard Murad Pharmaceutical compositions and methods for managing skin conditions
GB0018467D0 (en) * 2000-07-27 2000-09-13 Strakan Pharm Ltd Adhesives
WO2004064881A1 (en) 2003-01-24 2004-08-05 Insense Limited Skin treatment formulations
EP1670424A2 (en) * 2003-09-13 2006-06-21 Boots Healthcare International Limited Skincare compositions comprising salicylic acid
JP2008523899A (en) * 2004-12-21 2008-07-10 バクスター,エイプリル Nail polish tools and methods
US7511007B2 (en) * 2005-02-25 2009-03-31 Solutions Biomed, Llc Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
US8956333B2 (en) * 2005-04-22 2015-02-17 Alternamedics Llc Medication delivery device
BRPI0610180A2 (en) * 2005-05-24 2012-09-25 Wellgen Inc methods for preventing, treating, and treating or controlling a condition associated with inflammation
US20080025926A1 (en) 2006-07-24 2008-01-31 Dr. Nick's White & Healthy, Llc Oral care formulations with hydrogen peroxide and lycopene
US20100098645A1 (en) 2006-10-06 2010-04-22 Institute Of Technology Sligo Formulation and method for the treatment of fungal nail infections
ITPD20070242A1 (en) * 2007-07-17 2009-01-18 Farmogal S P A CONSERVATIVE COMPOSITION WITH ELECTROLYTIC SILVER FOR COSMETIC PRODUCTS
EP2482800A4 (en) * 2009-09-30 2013-10-30 Stiefel Res Australia Pty Ltd Cosmetic foam
BR112013008173A2 (en) * 2010-10-04 2017-12-05 Cupron Inc cosmetic compositions for skin care
CN104837470B (en) * 2012-12-14 2017-07-04 高露洁-棕榄公司 The oral care composition of peroxide stabilizer
GEP20197049B (en) * 2013-01-30 2019-12-10 Boris Gorinshteyn Compositions and methods for treating surface wounds
CA2946568C (en) 2014-04-21 2020-07-07 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same
KR101571095B1 (en) * 2015-04-13 2015-11-23 최용채 Water jet type toothbrush
ITUB20153759A1 (en) * 2015-09-21 2017-03-21 Federica Livieri ANTIFUNGAL COMPOSITION FOR TOPICAL USE FOR THE TREATMENT OF ANONICOMYOSIS AND RELATIVE METHOD

Also Published As

Publication number Publication date
JP2022522399A (en) 2022-04-19
EP3790529B1 (en) 2022-11-09
AU2020210126A1 (en) 2021-08-05
MX2021008491A (en) 2022-10-07
BR112021013705A2 (en) 2021-09-21
SI25540A (en) 2019-05-31
DK3790529T5 (en) 2023-04-24
CN113365597A (en) 2021-09-07
ZA202105832B (en) 2022-08-31
DK3790529T3 (en) 2023-01-23
EP3790529B8 (en) 2023-02-08
KR102651050B1 (en) 2024-03-25
KR20210114017A (en) 2021-09-17
EP3790529A1 (en) 2021-03-17
WO2020148642A1 (en) 2020-07-23
AU2020210126B2 (en) 2021-10-07
HRP20221515T1 (en) 2023-04-14
WO2020148642A4 (en) 2020-09-10
SI3790529T1 (en) 2023-04-28
CA3109813A1 (en) 2020-07-23
LT3790529T (en) 2023-03-10
US20220062124A1 (en) 2022-03-03
MY194346A (en) 2022-11-29
FI3790529T3 (en) 2023-01-31
HUE061288T2 (en) 2023-06-28
ES2934987T3 (en) 2023-02-28

Similar Documents

Publication Publication Date Title
HK1247822A1 (en) Formulations for oral administration of active agents
IL202785A0 (en) Use of homo-and copolymers for stabilizing active ingredient formulations
ZA202105832B (en) Formulations containing active oxygen compounds and devices for application thereof
PH12019502548A1 (en) Pyrazole magl inhibitors
EP3500291A4 (en) Formulations for oral administration of active agents
IL271036B (en) Substituted nitrogen containing hererocyclic compounds as inhibitors of romk channel activity and using such compounds for the treatment of cardiovascular diseases
EP3827810A4 (en) Cosmetic composition containing galactomyces-derived exosome as active ingredient
MX2019010330A (en) Formulations with improved stability.
IL288531A (en) Wide-spectrum antibacterial pharmaceutical formulations comprising lysozyme and methods of using the same
EP4015042A4 (en) Pharmaceutical composition containing antifungal agent as active ingredient
EP3810118A4 (en) Formulations of tegavivint and related compounds
EP3654950A4 (en) Microparticle formulations for delivery of active agents
EP4088731A4 (en) Composition containing peptide or peptide compound as active ingredient, and medical use therefor
EP3626703A4 (en) Novel compound and pharmaceutical composition comprising same as active ingredient
EP3893847A4 (en) Stable formulations of anesthetics and associated dosage forms
EP3741373A4 (en) Use of carrimycin or active ingredient thereof
EP3676612A4 (en) Composition for stabilization of antibody formulations containing percp
IL285005A (en) Compositions comprising thymoquinone and additional biologically active compounds
GB202211063D0 (en) Catechin containing formulations and uses
GB202209022D0 (en) Pharmaceutical compositions and formulations for the treatment of retinoblastoma
GB202101161D0 (en) Formulations for the treatment of tendinopathies
GB201909815D0 (en) Active placebo system
EP3955907A4 (en) Pharmaceutical formulations containing p2y14 antagonists
GB202215133D0 (en) Creamy substance
GB202115200D0 (en) Retentive formulation